{"id":"W4399880973","doi":"10.1016/j.jtct.2024.06.018","title":"Applying Implementation Science in the Field of Transplant and Cellular Therapy","year":2024,"lang":"en","type":"review","venue":"Transplantation and Cellular Therapy","topic":"Health Policy Implementation Science","field":"Health Professions","cited_by":4,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"National Institute of Environmental Health Sciences; National Institute of Allergy and Infectious Diseases; Office of Naval Research; Legend Biotech; NYU Grossman School of Medicine; Pharmacyclics; Takeda Oncology; Health Resources and Services Administration; National Institutes of Health; MorphoSys; Seagen; BeiGene; Astellas Pharma; Adaptive Biotechnologies; Kiadis Pharma; bluebird bio; Medac; Jazz Pharmaceuticals; Amgen; Rush University; HistoGenetics; U.S. Public Health Service; U.S. Department of Defense; Sanofi; GlaxoSmithKline; National Institute on Aging; CSL Behring; Bristol-Myers Squibb; AstraZeneca; Swedish Orphan Biovitrum; Omeros Corporation; Vertex Pharmaceuticals; Alexion Pharmaceuticals; Mallinckrodt Pharmaceuticals; Astellas Pharma US; U.S. Navy; Gateway for Cancer Research; Actinium Pharmaceuticals; CareDx; National Heart, Lung, and Blood Institute; Novartis Pharmaceuticals Corporation; Incyte; Pfizer; Atara Biotherapeutics; National Cancer Institute; Gilead Sciences","keywords":"Field (mathematics); Computer science; Mathematics","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004025744,0.0003450615,0.0007230662,0.0005927024,0.0005694717,0.00005786669,0.0004093948,0.000199991,0.0001785166],"category_scores_gemma":[0.00001542143,0.0002193587,0.0001044456,0.001080359,0.0002295011,0.0002185406,0.00001497862,0.0006653719,0.00001782437],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005810436,"about_ca_system_score_gemma":0.0007858134,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000447094,"about_ca_topic_score_gemma":0.0001731455,"domain_scores_codex":[0.9957905,0.001147758,0.001352627,0.0005379402,0.0006103205,0.0005607919],"domain_scores_gemma":[0.9974113,0.001712491,0.0004063821,0.0002859173,0.00006415235,0.0001198201],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00005164293,0.00002577568,0.0002497981,0.01423665,0.00003099431,0.00002019886,0.05369574,1.340327e-7,0.0009339565,0.002248384,0.0001266008,0.9283801],"study_design_scores_gemma":[0.002207831,0.0002830753,0.0001933727,0.004830788,0.0002270849,0.00002297936,0.005709574,0.00001815563,0.0009141933,0.0003658322,0.9847842,0.0004429547],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01376439,0.9770785,0.0009340529,0.0008593529,0.0004002192,0.006193975,0.0002364921,0.00004337945,0.000489667],"genre_scores_gemma":[0.01539609,0.9802899,0.00007894005,0.002700763,0.00008799578,0.001268895,0.0001095736,0.00003147994,0.0000363645],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9846576,"threshold_uncertainty_score":0.894519,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.4059776011179404,"score_gpt":0.6240151996592307,"score_spread":0.2180375985412903,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}